Effectiveness of maintenance treatments for nonsmall cell lung cancer
Matthew J Eadens, Steven I Robinson, Katharine AR PriceDivision of Medical Oncology, Mayo Clinic, Rochester, MN, USAAbstract: Maintenance therapy for advanced nonsmall cell lung cancer has shown some clinical benefit for patients by improving progression-free survival and, to a lesser extent, overal...
Guardado en:
Autores principales: | Eadens MJ, Robinson SI, Price KA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/90c5a1acfc5a43d99148aab98eb8272c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer
por: Zienolddiny S, et al.
Publicado: (2011) -
Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study
por: Jie Zhang PhD, et al.
Publicado: (2021) -
Hypofractionated stereotactic body radiation therapy for elderly patients with stage IIB–IV nonsmall cell lung cancer who are ineligible for or refuse other treatment modalities
por: Karam SD, et al.
Publicado: (2014) -
Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
por: Minami S, et al.
Publicado: (2015) -
Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity
por: Cobo M, et al.
Publicado: (2017)